Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ssebambulidde

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Open Forum Infectious Diseases|February 26, 2025
Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort StudyLaura Nsangi, Kathy Huppler Hullsiek, Biyue Dai, et al.
Medical Mycology|January 5, 2021
Impact of biological sex on cryptococcal meningitis mortality in Uganda and South AfricaAnna M Stadelman, Kenneth Ssebambulidde, Lillian Tugume, et al.
The Journal of Infectious Diseases|August 29, 2024
Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal MeningitisElizabeth C Okafor, Liliane Mukaremera, Kathy H Hullsiek, et al.
The Journal of Infectious Diseases|October 17, 2018
HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 CountsLillian Tugume, Joshua Rhein, Kathy Huppler Hullsiek, et al.
AIDS Research and Human Retroviruses|March 8, 2021
Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal MeningitisSarah M Lofgren, Melanie R Nicol, Tadeo K Kandole, et al.
Journal of Fungi (Basel, Switzerland)|January 21, 2023
Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High MortalityCaleb P Skipper, Katherine Huppler Hullsiek, Anna Stadelman, et al.
Journal of Clinical Medicine|March 19, 2020
Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of DeathMorris K Rutakingirwa, Fiona V Cresswell, Richard Kwizera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2020
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal MeningitisMahsa Abassi, Ananta S Bangdiwala, Edwin Nuwagira, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Open Forum Infectious Diseases|February 26, 2025
Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort StudyLaura Nsangi, Kathy Huppler Hullsiek, Biyue Dai, et al.
Medical Mycology|January 5, 2021
Impact of biological sex on cryptococcal meningitis mortality in Uganda and South AfricaAnna M Stadelman, Kenneth Ssebambulidde, Lillian Tugume, et al.
The Journal of Infectious Diseases|August 29, 2024
Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal MeningitisElizabeth C Okafor, Liliane Mukaremera, Kathy H Hullsiek, et al.
The Journal of Infectious Diseases|October 17, 2018
HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 CountsLillian Tugume, Joshua Rhein, Kathy Huppler Hullsiek, et al.
AIDS Research and Human Retroviruses|March 8, 2021
Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal MeningitisSarah M Lofgren, Melanie R Nicol, Tadeo K Kandole, et al.
Journal of Fungi (Basel, Switzerland)|January 21, 2023
Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High MortalityCaleb P Skipper, Katherine Huppler Hullsiek, Anna Stadelman, et al.
Journal of Clinical Medicine|March 19, 2020
Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of DeathMorris K Rutakingirwa, Fiona V Cresswell, Richard Kwizera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2020
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal MeningitisMahsa Abassi, Ananta S Bangdiwala, Edwin Nuwagira, et al.
Pageof 8